Skip to main page content

Jack Mouhanna

Participates in 4 items

Sessions in which Jack Mouhanna participates

الأحد 27 يونيو, 2021

Time Zone: (GMT-05:00) Eastern Time (US & Canada)
18:25
18:27 - 18:35 | 8 minutes
Neuro-ophthalmology

Access the Live Meeting: https://www.yourconference.live/COS Authors: Jack G. Mouhanna, Wei Sim, Danah Albreiki. Disclosure Block: J.G. Mouhanna: None. W. Sim: None. D. Albreiki: None. Abstract Body: Purpose: Tocilizumab (TCZ) is an IL-6 recept...

الأحد 22 يونيو, 2025

Time Zone: (GMT-05:00) Eastern Time (US & Canada)
12:30
12:30 - 12:40 | 10 minutes

Author’s Name(s): Jack Mouhanna, Sheetal Pundir, Jesia HasanAuthor’s Disclosure Block: Jack Mouhanna, none; Sheetal Pundir, none; Jesia Hasan, noneAbstract BodyPurpose:Immune checkpoint inhibitors and targeted therapies are the mainstay treatment for advanced melanoma. The combination of a BRAF kinase inhibitor (BRAFi) and a MEK kinase inhibitor (MEKi) is particularly effective in patients with melanoma harboring the common ...

12:40
12:40 - 12:45 | 5 minutes
14:05
14:05 - 14:10 | 5 minutes

Author’s Name(s): Jack Mouhanna, Guillermo RochaAuthor’s Disclosure Block: Jack Mouhanna, none; Guillermo Rocha, noneAbstract BodyPurpose: Post-operative corneal edema is an important consideration in patients with Fuchs corneal endothelial dystrophy (FECD) undergoing cataract surgery. Decision-making for combined cataract surgery and endothelial keratoplasty in cases with early FECD is particularly challenging given the lac...